Level D· Scientific groundwork from lab and animal studiesNarrative ReviewEurope PMC

Wound coverage technologies in burn care: novel techniques

Jeschke MG., Finnerty CC., Shahrokhi S., Branski LK., Dibildox M., ABA Organization and Delivery of Burn Care Committee

Narrative Review on Chronic Wound, Burns, Scar, published in J Burn Care Res (2013) — summary generated from the PubMed abstract.

Open my reading list
Level D· Scientific groundwork from lab and animal studiesEvidence level of this study

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

  • Level A · Stronger Clinical Evidence
  • Level B · Emerging clinical evidence with positive signals
  • Level C · Early human research exploring benefits
  • Level D · Scientific groundwork from lab and animal studies
  • Emerging · Emerging topic under active research
Read the A–D evidence level guide

This page is generated from the PubMed record. The Thai description is an automated summary of bibliographic fields and the abstract, not a full translation, and is not medical advice.

Study type
Narrative Review
Journal
J Burn Care Res (2013)
Reported sample size
—
Source database
Europe PMC
PMID
23877140
PMCID
PMC3819403
DOI
10.1097/bcr.0b013e31829b0075
Citations
26

Abstract (original English)

Improvements in burn wound care have vastly decreased morbidity and mortality in severely burned patients. Development of new therapeutic approaches to increase wound repair has the potential to reduce infection, graft rejection, and hypertrophic scarring. The incorporation of tissue-engineering techniques, along with the use of exogenous proteins, genes, or stem cells to enhance wound healing, heralds new treatment regimens based on the modification of already existing biological activity. Refinements to surgical techniques have enabled the creation of protocols for full facial transplantation. With new technologies and advances such as these, care of the severely burned will undergo massive changes over the next decade. This review centers on new developments that have recently shown great promise in the investigational arena.

What this study does not prove

  • • This study does not prove SVF is an approved treatment or a replacement for standard care.
  • • This is a narrative review: it collects no new patient data and does not systematically appraise evidence quality.

Evidence level

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

How we grade evidence
CicatrixAnimalsHumansCross InfectionBurnsFibrin Tissue AdhesiveSkin CareStem Cell TransplantationSkin TransplantationTissue Engineering

Browse all related research

Filter the research library by this study's title keywords, author, or publication year.

Related research